Complementary methodologies for rare cancers: Worth discussing?

14 octubre 2014

Rare Cancers Europe (RCE) is a multi stakeholder initiative promoted by ESMO dedicated to putting rare cancers on the European political agenda. In their consensus document, RCE argue that a higher degree of uncertainty should be accepted for regulatory as well as clinically informed decision-making in rare cancers, to overcome the limitations imposed by small population trials.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/oMjA0m2fgLc/141014152531.htm

Volver